Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Hemo Organic is engaged in manufacturing of ayurvedic medicines.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Hemo Organic Limited - 524590 - Submission Of Un-Audited Financial Results Along With Limited Review Report For The Quarter And Half Year Ended On 30Th September, 2024. | Download
Hemo Organic Limited - 524590 - Submission Of Un-Audited Financial Results Along With Limited Review Report For The Quarter And Half Year Ended On 30Th September, 2024. | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant